The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Infectious Disease Diagnostic Testing Market Research Report 2025
Synopsis
The global Infectious Disease Diagnostic Testing market was valued at US$ 16500 million in 2023 and is anticipated to reach US$ 21090 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Diagnostic Testing.
Report Scope
The Infectious Disease Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Abbott
bioMerieux
Diasorin
Roche Diagnostic
BD
Gold Standard Diagnostics
Hologic
Siemens Healthcare Diagnostics
TECHLAB
Bio-Rad Laboratories
Corgenix
Cepheid
Meridian Bioscience
Segment by Type
Molecular Diagnostic Test
POC Infectious Disease Diagnostics Test
Segment by Application
HIV
HAIs
Respiratory
Tropical Diseases
Liver
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Infectious Disease Diagnostic Testing market was valued at US$ 16500 million in 2023 and is anticipated to reach US$ 21090 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Diagnostic Testing.
Report Scope
The Infectious Disease Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Abbott
bioMerieux
Diasorin
Roche Diagnostic
BD
Gold Standard Diagnostics
Hologic
Siemens Healthcare Diagnostics
TECHLAB
Bio-Rad Laboratories
Corgenix
Cepheid
Meridian Bioscience
Segment by Type
Molecular Diagnostic Test
POC Infectious Disease Diagnostics Test
Segment by Application
HIV
HAIs
Respiratory
Tropical Diseases
Liver
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Diagnostic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Molecular Diagnostic Test
1.2.3 POC Infectious Disease Diagnostics Test
1.3 Market by Application
1.3.1 Global Infectious Disease Diagnostic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 HIV
1.3.3 HAIs
1.3.4 Respiratory
1.3.5 Tropical Diseases
1.3.6 Liver
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Diagnostic Testing Market Perspective (2019-2030)
2.2 Infectious Disease Diagnostic Testing Growth Trends by Region
2.2.1 Global Infectious Disease Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Disease Diagnostic Testing Historic Market Size by Region (2019-2024)
2.2.3 Infectious Disease Diagnostic Testing Forecasted Market Size by Region (2025-2030)
2.3 Infectious Disease Diagnostic Testing Market Dynamics
2.3.1 Infectious Disease Diagnostic Testing Industry Trends
2.3.2 Infectious Disease Diagnostic Testing Market Drivers
2.3.3 Infectious Disease Diagnostic Testing Market Challenges
2.3.4 Infectious Disease Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Diagnostic Testing Players by Revenue
3.1.1 Global Top Infectious Disease Diagnostic Testing Players by Revenue (2019-2024)
3.1.2 Global Infectious Disease Diagnostic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Disease Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Diagnostic Testing Revenue
3.4 Global Infectious Disease Diagnostic Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostic Testing Revenue in 2023
3.5 Infectious Disease Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Infectious Disease Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Infectious Disease Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Diagnostic Testing Breakdown Data by Type
4.1 Global Infectious Disease Diagnostic Testing Historic Market Size by Type (2019-2024)
4.2 Global Infectious Disease Diagnostic Testing Forecasted Market Size by Type (2025-2030)
5 Infectious Disease Diagnostic Testing Breakdown Data by Application
5.1 Global Infectious Disease Diagnostic Testing Historic Market Size by Application (2019-2024)
5.2 Global Infectious Disease Diagnostic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Disease Diagnostic Testing Market Size (2019-2030)
6.2 North America Infectious Disease Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infectious Disease Diagnostic Testing Market Size by Country (2019-2024)
6.4 North America Infectious Disease Diagnostic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Diagnostic Testing Market Size (2019-2030)
7.2 Europe Infectious Disease Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infectious Disease Diagnostic Testing Market Size by Country (2019-2024)
7.4 Europe Infectious Disease Diagnostic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Diagnostic Testing Market Size (2019-2030)
8.2 Asia-Pacific Infectious Disease Diagnostic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infectious Disease Diagnostic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Infectious Disease Diagnostic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Diagnostic Testing Market Size (2019-2030)
9.2 Latin America Infectious Disease Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infectious Disease Diagnostic Testing Market Size by Country (2019-2024)
9.4 Latin America Infectious Disease Diagnostic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Diagnostic Testing Market Size (2019-2030)
10.2 Middle East & Africa Infectious Disease Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Infectious Disease Diagnostic Testing Introduction
11.1.4 Abbott Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Infectious Disease Diagnostic Testing Introduction
11.2.4 Abbott Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 bioMerieux
11.3.1 bioMerieux Company Detail
11.3.2 bioMerieux Business Overview
11.3.3 bioMerieux Infectious Disease Diagnostic Testing Introduction
11.3.4 bioMerieux Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.3.5 bioMerieux Recent Development
11.4 Diasorin
11.4.1 Diasorin Company Detail
11.4.2 Diasorin Business Overview
11.4.3 Diasorin Infectious Disease Diagnostic Testing Introduction
11.4.4 Diasorin Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.4.5 Diasorin Recent Development
11.5 Roche Diagnostic
11.5.1 Roche Diagnostic Company Detail
11.5.2 Roche Diagnostic Business Overview
11.5.3 Roche Diagnostic Infectious Disease Diagnostic Testing Introduction
11.5.4 Roche Diagnostic Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.5.5 Roche Diagnostic Recent Development
11.6 BD
11.6.1 BD Company Detail
11.6.2 BD Business Overview
11.6.3 BD Infectious Disease Diagnostic Testing Introduction
11.6.4 BD Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.6.5 BD Recent Development
11.7 Gold Standard Diagnostics
11.7.1 Gold Standard Diagnostics Company Detail
11.7.2 Gold Standard Diagnostics Business Overview
11.7.3 Gold Standard Diagnostics Infectious Disease Diagnostic Testing Introduction
11.7.4 Gold Standard Diagnostics Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.7.5 Gold Standard Diagnostics Recent Development
11.8 Hologic
11.8.1 Hologic Company Detail
11.8.2 Hologic Business Overview
11.8.3 Hologic Infectious Disease Diagnostic Testing Introduction
11.8.4 Hologic Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.8.5 Hologic Recent Development
11.9 Siemens Healthcare Diagnostics
11.9.1 Siemens Healthcare Diagnostics Company Detail
11.9.2 Siemens Healthcare Diagnostics Business Overview
11.9.3 Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Introduction
11.9.4 Siemens Healthcare Diagnostics Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.9.5 Siemens Healthcare Diagnostics Recent Development
11.10 TECHLAB
11.10.1 TECHLAB Company Detail
11.10.2 TECHLAB Business Overview
11.10.3 TECHLAB Infectious Disease Diagnostic Testing Introduction
11.10.4 TECHLAB Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.10.5 TECHLAB Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Infectious Disease Diagnostic Testing Introduction
11.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Corgenix
11.12.1 Corgenix Company Detail
11.12.2 Corgenix Business Overview
11.12.3 Corgenix Infectious Disease Diagnostic Testing Introduction
11.12.4 Corgenix Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.12.5 Corgenix Recent Development
11.13 Cepheid
11.13.1 Cepheid Company Detail
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Infectious Disease Diagnostic Testing Introduction
11.13.4 Cepheid Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.13.5 Cepheid Recent Development
11.14 Meridian Bioscience
11.14.1 Meridian Bioscience Company Detail
11.14.2 Meridian Bioscience Business Overview
11.14.3 Meridian Bioscience Infectious Disease Diagnostic Testing Introduction
11.14.4 Meridian Bioscience Revenue in Infectious Disease Diagnostic Testing Business (2019-2024)
11.14.5 Meridian Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Infectious Disease Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Molecular Diagnostic Test
Table 3. Key Players of POC Infectious Disease Diagnostics Test
Table 4. Global Infectious Disease Diagnostic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Infectious Disease Diagnostic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Infectious Disease Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Infectious Disease Diagnostic Testing Market Share by Region (2019-2024)
Table 8. Global Infectious Disease Diagnostic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Infectious Disease Diagnostic Testing Market Share by Region (2025-2030)
Table 10. Infectious Disease Diagnostic Testing Market Trends
Table 11. Infectious Disease Diagnostic Testing Market Drivers
Table 12. Infectious Disease Diagnostic Testing Market Challenges
Table 13. Infectious Disease Diagnostic Testing Market Restraints
Table 14. Global Infectious Disease Diagnostic Testing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Infectious Disease Diagnostic Testing Market Share by Players (2019-2024)
Table 16. Global Top Infectious Disease Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostic Testing as of 2023)
Table 17. Ranking of Global Top Infectious Disease Diagnostic Testing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Infectious Disease Diagnostic Testing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Infectious Disease Diagnostic Testing Product Solution and Service
Table 21. Date of Enter into Infectious Disease Diagnostic Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Infectious Disease Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Infectious Disease Diagnostic Testing Revenue Market Share by Type (2019-2024)
Table 25. Global Infectious Disease Diagnostic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Infectious Disease Diagnostic Testing Revenue Market Share by Type (2025-2030)
Table 27. Global Infectious Disease Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Infectious Disease Diagnostic Testing Revenue Market Share by Application (2019-2024)
Table 29. Global Infectious Disease Diagnostic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Infectious Disease Diagnostic Testing Revenue Market Share by Application (2025-2030)
Table 31. North America Infectious Disease Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Infectious Disease Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Infectious Disease Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Infectious Disease Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Infectious Disease Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Infectious Disease Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Infectious Disease Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Infectious Disease Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Infectious Disease Diagnostic Testing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Infectious Disease Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Infectious Disease Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Infectious Disease Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Infectious Disease Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Infectious Disease Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbott Company Detail
Table 47. Abbott Business Overview
Table 48. Abbott Infectious Disease Diagnostic Testing Product
Table 49. Abbott Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. Abbott Company Detail
Table 52. Abbott Business Overview
Table 53. Abbott Infectious Disease Diagnostic Testing Product
Table 54. Abbott Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. bioMerieux Company Detail
Table 57. bioMerieux Business Overview
Table 58. bioMerieux Infectious Disease Diagnostic Testing Product
Table 59. bioMerieux Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 60. bioMerieux Recent Development
Table 61. Diasorin Company Detail
Table 62. Diasorin Business Overview
Table 63. Diasorin Infectious Disease Diagnostic Testing Product
Table 64. Diasorin Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 65. Diasorin Recent Development
Table 66. Roche Diagnostic Company Detail
Table 67. Roche Diagnostic Business Overview
Table 68. Roche Diagnostic Infectious Disease Diagnostic Testing Product
Table 69. Roche Diagnostic Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 70. Roche Diagnostic Recent Development
Table 71. BD Company Detail
Table 72. BD Business Overview
Table 73. BD Infectious Disease Diagnostic Testing Product
Table 74. BD Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 75. BD Recent Development
Table 76. Gold Standard Diagnostics Company Detail
Table 77. Gold Standard Diagnostics Business Overview
Table 78. Gold Standard Diagnostics Infectious Disease Diagnostic Testing Product
Table 79. Gold Standard Diagnostics Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 80. Gold Standard Diagnostics Recent Development
Table 81. Hologic Company Detail
Table 82. Hologic Business Overview
Table 83. Hologic Infectious Disease Diagnostic Testing Product
Table 84. Hologic Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 85. Hologic Recent Development
Table 86. Siemens Healthcare Diagnostics Company Detail
Table 87. Siemens Healthcare Diagnostics Business Overview
Table 88. Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Product
Table 89. Siemens Healthcare Diagnostics Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 90. Siemens Healthcare Diagnostics Recent Development
Table 91. TECHLAB Company Detail
Table 92. TECHLAB Business Overview
Table 93. TECHLAB Infectious Disease Diagnostic Testing Product
Table 94. TECHLAB Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 95. TECHLAB Recent Development
Table 96. Bio-Rad Laboratories Company Detail
Table 97. Bio-Rad Laboratories Business Overview
Table 98. Bio-Rad Laboratories Infectious Disease Diagnostic Testing Product
Table 99. Bio-Rad Laboratories Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 100. Bio-Rad Laboratories Recent Development
Table 101. Corgenix Company Detail
Table 102. Corgenix Business Overview
Table 103. Corgenix Infectious Disease Diagnostic Testing Product
Table 104. Corgenix Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 105. Corgenix Recent Development
Table 106. Cepheid Company Detail
Table 107. Cepheid Business Overview
Table 108. Cepheid Infectious Disease Diagnostic Testing Product
Table 109. Cepheid Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 110. Cepheid Recent Development
Table 111. Meridian Bioscience Company Detail
Table 112. Meridian Bioscience Business Overview
Table 113. Meridian Bioscience Infectious Disease Diagnostic Testing Product
Table 114. Meridian Bioscience Revenue in Infectious Disease Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 115. Meridian Bioscience Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Diagnostic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Infectious Disease Diagnostic Testing Market Share by Type: 2023 VS 2030
Figure 3. Molecular Diagnostic Test Features
Figure 4. POC Infectious Disease Diagnostics Test Features
Figure 5. Global Infectious Disease Diagnostic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Infectious Disease Diagnostic Testing Market Share by Application: 2023 VS 2030
Figure 7. HIV Case Studies
Figure 8. HAIs Case Studies
Figure 9. Respiratory Case Studies
Figure 10. Tropical Diseases Case Studies
Figure 11. Liver Case Studies
Figure 12. Others Case Studies
Figure 13. Infectious Disease Diagnostic Testing Report Years Considered
Figure 14. Global Infectious Disease Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Infectious Disease Diagnostic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Infectious Disease Diagnostic Testing Market Share by Region: 2023 VS 2030
Figure 17. Global Infectious Disease Diagnostic Testing Market Share by Players in 2023
Figure 18. Global Top Infectious Disease Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostic Testing as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Infectious Disease Diagnostic Testing Revenue in 2023
Figure 20. North America Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Infectious Disease Diagnostic Testing Market Share by Country (2019-2030)
Figure 22. United States Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Infectious Disease Diagnostic Testing Market Share by Country (2019-2030)
Figure 26. Germany Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Infectious Disease Diagnostic Testing Market Share by Region (2019-2030)
Figure 34. China Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Infectious Disease Diagnostic Testing Market Share by Country (2019-2030)
Figure 42. Mexico Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Infectious Disease Diagnostic Testing Market Share by Country (2019-2030)
Figure 46. Turkey Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Infectious Disease Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 49. Abbott Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 50. bioMerieux Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 51. Diasorin Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 52. Roche Diagnostic Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 53. BD Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 54. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 55. Hologic Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 56. Siemens Healthcare Diagnostics Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 57. TECHLAB Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 59. Corgenix Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 60. Cepheid Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 61. Meridian Bioscience Revenue Growth Rate in Infectious Disease Diagnostic Testing Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
